Shanghai Fudan Forward S&T Co (600624.SS) Stock Price

Shanghai Fudan Forward S&T Co Price

SSE·CLOSED

4.16

Market closed

Terminal

Revenue has compounded at 2.7% per year over the past 19 years to 640.13 M CNY. Earnings per share have grown at 8.6% per year over the last 13 years. Shanghai Fudan Forward S&T Co's net margin stands at -30.9%, down from -10.1% several years earlier. Shanghai Fudan Forward S&T Co currently offers a dividend yield of about 0.65%. The dividend has grown at 2.9% per year over the past 14 years.

Shanghai Fudan Forward S&T Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Docs Get Free API Key

Shanghai Fudan Forward S&T Co business model & stock analysis

Shanghai Fudan Forward S&T Co., Ltd. generates revenue through the research, development, production, and sale of pharmaceutical products, including digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, and immune function medications. The company also provides financial insurance software products. Its domestic and overseas markets serve as key sales channels for these pharmaceuticals and software solutions. The firm's product portfolio targets healthcare providers, hospitals, and pharmacies within the pharmaceutical sector. The company's pharmaceutical segment focuses on specialized drug categories such as digestive system and nervous system treatments, alongside antineoplastic and circulatory drugs. Financial insurance software products complement its core pharmaceutical business, offering additional revenue streams. Domestic markets account for a significant portion of sales, while overseas markets expand its global reach. Shanghai Fudan Forward S&T Co., Ltd. leverages its 1,426 full-time employees to support both pharmaceutical and software operations. The firm's product offerings cater to healthcare institutions requiring specialized medications and digital solutions for insurance management. This dual focus allows the company to serve multiple segments within the healthcare and financial technology industries.

Frequently asked questions about Shanghai Fudan Forward S&T Co

What is the Shanghai Fudan Forward S&T Co share price in euros (EUR)?

Converted at the current exchange rate, the Shanghai Fudan Forward S&T Co share trades at 0.55 EUR (4.16 CNY).

On which stock exchanges is the Shanghai Fudan Forward S&T Co share traded?

The Shanghai Fudan Forward S&T Co share (600624.SS) is listed on 1 stock exchanges, including: Shanghai (600624.SS).

What is the business model of Shanghai Fudan Forward S&T Co?

What is the revenue of Shanghai Fudan Forward S&T Co 2026?

The revenue cannot currently be calculated for Shanghai Fudan Forward S&T Co.

How high is the profit of Shanghai Fudan Forward S&T Co 2026?

The profit cannot currently be calculated for Shanghai Fudan Forward S&T Co.

What is the P/E ratio of Shanghai Fudan Forward S&T Co 2026?

The P/E ratio cannot be calculated for Shanghai Fudan Forward S&T Co at the moment.

What is the P/S ratio of Shanghai Fudan Forward S&T Co 2026?

The P/S cannot be calculated for Shanghai Fudan Forward S&T Co currently.

What is the Eulerpool Quality Score of Shanghai Fudan Forward S&T Co?

The Eulerpool Quality Score for Shanghai Fudan Forward S&T Co is 1/10.

What is the Shanghai Fudan Forward S&T Co ISIN?

The ISIN of Shanghai Fudan Forward S&T Co is CNE0000006S1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

What is the Shanghai Fudan Forward S&T Co ticker?

The ticker of Shanghai Fudan Forward S&T Co is 600624.SS. The ticker symbol is used to trade Shanghai Fudan Forward S&T Co shares on the stock exchange.

Fair ValueTerminal

4.04 CNY

Over-/UndervaluationTerminal

Fairly valued

Sector

Health

Industry

Pharmaceuticals

Number of shares

679,350,000

Employees

1,426

Revenue per Employee

448,896.67 CNY

Revenue growth Ø5 years

-9.27 %

EBIT growth Ø5 years

-6.63 %

Net Income growth Ø5 years

13.38 %

Website forwardgroup.com

Country

China

Currency

CNY

Initial public offering

Jan 5, 1993

ISIN

CNE0000006S1

Cusip

Y2617R104

Market capitalization

2.83 B CNYMid Cap

52-Week Range

Shanghai Fudan Forward S&T Co Directors Dealings

Quality Investing

1 / 10

PEG

—

P/E ratio

-12.98

P/Ee

—

P/S

4.01

P/Se

—

EV/EBIT

—

P/B Ratio

6.45

ROE (Return on Equity)

-45.09 %

ROA (Return on Assets)

-14.59 %

ROCE (Return on Capital Employed)

-9.16 %

ROIC (Return on Invested Capital)

-45.09 %

Dividend

0.00 CNY

Dividend yield

0.00 %

Payout Ratio

35.50 %

Dividend growth Ø5Y

8.09 %

Dividend payments per year

Dividend paid since

0 years

Dividend not reduced since

0 years

Dividend increased since

0 years

Dividend withholding tax

10.00 %

Last updated Oct 21, 2026, 12:57 PM

Shanghai Fudan Forward S&T Co Peer Group

Shanghai Fudan Forward S&T Co Ticker

SHH · 600624.SS

Shanghai Fudan Forward S&T Co FIGI

600624:CH · BBG000BFY4X1600624:CG · BBG000BFY5B2600624:C1 · BBG00709HY83

All fundamentals and in-depth analysis of Shanghai Fudan Forward S&T Co

Our stock analysis for Shanghai Fudan Forward S&T Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Fudan Forward S&T Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Shanghai Fudan Forward S&T Co Revenue→

Shanghai Fudan Forward S&T Co Net Income→

Shanghai Fudan Forward S&T Co P/E→

Shanghai Fudan Forward S&T Co P/S→

Shanghai Fudan Forward S&T Co EBIT→

Shanghai Fudan Forward S&T Co Dividend→

Shanghai Fudan Forward S&T Co Directors Dealings→

Shanghai Fudan Forward S&T Co Stocks→

Shanghai Fudan Forward S&T Co Market capitalization→

Shanghai Fudan Forward S&T Co Debt→

Shanghai Fudan Forward S&T Co Liabilities→

Shanghai Fudan Forward S&T Co Equity→